Korean Circ J.  2018 Apr;48(4):241-250. 10.4070/kcj.2018.0066.

Automated Office Blood Pressure Measurement

• Myers MG

• KMID: 2407895
• DOI: http://doi.org/10.4070/kcj.2018.0066

Abstract

Manual blood pressure (BP) recorded in routine clinical practice is relatively inaccurate and associated with higher readings compared to BP measured in research studies in accordance with standardized measurement guidelines. The increase in routine office BP is the result of several factors, especially the presence of office staff, which tends to make patients nervous and also allows for conversation to occur. With the disappearance of the mercury sphygmomanometer because of environmental concerns, there is greater use of oscillometric BP recorders, both in the office setting and elsewhere. Although oscillometric devices may reduce some aspects of observer BP measurement error in the clinical setting, they are still associated with higher BP readings, known as white coat hypertension (for diagnosis) or white coat effect (with treated hypertension). Now that fully automated sphygmomanometers are available which are capable of recording several readings with the patient resting quietly, there is no longer any need to have office staff present when BP is being recorded. Such readings are called automated office blood pressure (AOBP) and they are both more accurate than conventional manual office BP and not associated with the white coat phenomena. AOBP readings are also similar to the awake ambulatory BP and home BP, both of which are relatively good predictors of cardiovascular risk. The available evidence suggests that AOBP should now replace manual or electronic office BP readings when screening patients for hypertension and also after antihypertensive drug therapy is initiated.

Keyword

Blood pressure; Hypertension diagnosis; Measurement; Devices; Office

MeSH Terms

Blood Pressure*
Drug Therapy
Humans
Hypertension
Mass Screening
Reading
Sphygmomanometers
White Coat Hypertension

Reference

1. Myers MG, Oh P, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens. 1995; 8:591–597. PMID: 7662244.

2. Myers MG, Meglis G, Polemidiotis G. The impact of physician vs automated blood pressure readings on office-induced hypertension. J Hum Hypertens. 1997; 11:491–493. PMID: 9322829.

3. Myers MG, Valdivieso MA. Use of an automated blood pressure recording device, the BpTRU, to reduce the “white coat effect” in routine practice. Am J Hypertens. 2003; 16:494–497. PMID: 12799100.

4. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension. 2010; 55:195–200. PMID: 20038756.

5. Chambers LW, Kaczorowski J, O'Reilly S, Ignagni S, Hearps SJ. Comparison of blood pressure measurements using an automated blood pressure device in community pharmacies and family physicians' offices: a randomized controlled trial. CMAJ Open. 2013; 1:E37–E42.

6. Armstrong D, Matangi M, Brouillard D, Myers MG. Automated office blood pressure – being alone and not location is what matters most. Blood Press Monit. 2015; 20:204–208. PMID: 26154710.

7. Myers MG, Valdivieso M, Kiss A. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press Monit. 2009; 14:108–111. PMID: 19417634.

8. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24-h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2005; 5:18. PMID: 15985180.

9. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009; 27:280–286. PMID: 19155785.

10. Myers MG. A short history of automated office blood pressure – 15 years to SPRINT. J Clin Hypertens (Greenwich). 2016; 18:721–724. PMID: 27038200.

11. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. The conventional versus automated meeasurement of blood pressure in the office (CAMBO) trial: masked hypertension sub-study. J Hypertens. 2012; 30:1937–1941. PMID: 22828087.

12. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001; 14:1263–1269. PMID: 11775136.

13. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003; 17:823–827. PMID: 14704726.

14. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor. A 10-year follow-up study. J Hum Hypertens. 2003; 17:811–817. PMID: 14704724.

15. Head GA, Mihallidou AS, Duggan KA, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 2010; 340:c1104. PMID: 20392760.

16. Burgess SE, MacLaughlin EJ, Smith PA, Salcido A, Benton TJ. Blood pressure rising: differences between current clinical and recommended measurement techniques. J Am Soc Hypertens. 2011; 5:484–488. PMID: 22015319.

17. de la Sierra A, Banegas JR, Divison JA, et al. Ambulatory blood pressure in hypertensive patients with inclusion criteria for the SPRINT trial. J Am Soc Hypertens. 2016; 10:947–953.e5. PMID: 27865822.

18. Myers MG. A proposed algorithm for diagnosing hypertension using automated office blood pressure measurement. J Hypertens. 2010; 28:703–708. PMID: 20150823.

19. Myers MG, Valdivieso M, Chessman M, Kiss A. Can sphygmomanometers designed for self-measurement of blood pressure in the home be used in office practice? Blood Press Monit. 2010; 15:300–304. PMID: 20975533.

20. Godwin M, Birtwhistle R, Delva D, et al. Measuring blood pressure in the office setting: manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Fam Pract. 2011; 28:110–117. PMID: 20720213.

21. Andreadis EA, Agaliotis GD, Angelopoulos ET, Tsakanikas AP, Chaveles IA, Mousoulis GP. Automated office blood pressure and 24-h ambulatory measurements are equally associated with left ventricular mass index. Am J Hypertens. 2011; 24:661–666. PMID: 21415839.

22. Campbell NR, McKay DW, Conradson H, Lonn E, Title LM, Anderson T. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male fire-fighters. J Hum Hypertens. 2007; 21:588–590. PMID: 17377600.

23. Kaczorowski J, Chambers LW, Dolovich L, et al. Improving cardiovascular health at the population level: 39 community cluster randomized trial of Cardiovascular Health Awareness Program (CHAP). BMJ. 2011; 342:d442. PMID: 21300712.

24. Myers MG, Kaczorowski J, Paterson JM, Dolovich L, Tu K. Thresholds for diagnosing hypertension based upon automated office blood pressure measurements and cardiovascular risk. Hypertension. 2015; 66:489–495. PMID: 26269653.

25. Myers MG, Kaczorowski J, Dolovich L, Tu K, Paterson JM. Cardiovascular risk in hypertension in relation to achieved blood pressure using automated office blood pressure measurement. Hypertension. 2016; 68:866–872. PMID: 27528062.

26. SPRINT Research Group. A randomized trial of intensive versus standard blood pressure control. N Engl J Med. 2015; 373:2103–2116. PMID: 26551272.

27. Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood Ppressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [Epub ahead of print]. Hypertension. 2017; 2017.

28. Leung AA, Nerenberg K, Daskalopoulou SS, et al. Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016; 32:569–588. PMID: 27118291.

29. Muntner P, Whelton PK. Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment. J Am Coll Cardiol. 2017; 69:2446–2456. PMID: 28494981.

30. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Conventional versus automated measurement of blood pressure in the office (CAMBO) trial. Fam Pract. 2012; 29:376–382. PMID: 22117083.

31. Kaczorowski J, Myers MG, Gelfer M, et al. How do family physicians measure blood pressure in routine clinical practice: national survey of Canadian physicians. Can Fam Physician. 2017; 63:e193–e199. PMID: 28292817.

32. Myers MG, Reeves RA. White coat effect in treated hypertensive patients: sex differences. J Hum Hypertens. 1995; 9:729–733. PMID: 8551486.

33. Al-Karkhi I, Al-Rubaiy R, Rosenqvist U, Falk M, Nystrom FN. Comparisons of automated blood pressures in a primary health care setting with self-measurements at the office and at home using the Omron i-C10 device. Blood Press Monit. 2015; 20:98–103. PMID: 25341027.

34. Bauer F, Seibert FS, Rohn B, et al. Attended versus unattended blood pressure measurement in a real life setting. Hypertension. 2018; 71:243–249. PMID: 29255074.

35. Myers MG, Kaczorowski J. Office blood pressure is lower than awake ambulatory blood pressure at lower targets for treatment. J Clin Hypertens (Greenwich). 2017; 19:1210–1213. PMID: 28942618.

36. Mancia G, Fagard R, Krzysztof N, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens. 2013; 31:1281–1357. PMID: 23817082.

37. Piper MA, Evans CV, Burda BU, Margolis KL, O'Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventative Services Task Force. Ann Intern Med. 2015; 162:192–204. PMID: 25531400.